Skip to search formSkip to main contentSkip to account menu

chrysamine G

Known as: 3,3'-((1,1'-biphenyl)-4,4'-diylbis(azo))bis(6-hydroxybenzoic acid), disodium salt, chrysamine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzoatesBiphenyl Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.
Review
2012
Review
2012
Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease.
2007
2007
Polyfluorinated bis-styrylbenzene beta-amyloid plaque binding ligands.
beta-Amyloid (Abeta) binding affinities and specificities for six bis-styrylbenzenes with multiple magnetically equivalent… 
2007
2007
[ ${\beta}-Amyloid$ ] Imaging Probes
Imaging distribution of plaques in Alzheimer's disease is very important for early and accurate diagnosis. Early trial of the… 
Highly Cited
2001
Highly Cited
2001
Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles
Huntington's disease (HD) is a late onset neurodegenerative disorder caused by a CAG/polyglutamine (polyQ) repeat expansion… 
2001
2001
Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis
To date, systemic amyloidosis is diagnosed histologi-cally using Congo red staining or in vivo using iodine-123 labelled serum… 
2001
2001
In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis
To date, systemic amyloidosis is diagnosed histologically in vitro using Congo red staining or in vivo using iodine-123 serum… 
2001
2001
Chrysamine G(CG)は線維性Aβの神経毒性を抑制する
Highly Cited
1999
Highly Cited
1999
99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease
Abstract. Chrysamine G (CG), an analogue of Congo red, is known to bind in vitro to the β-amyloid protein (Aβ 10-43) and to… 
1998
1998
Derives d'alkyle, d'alcenyle et d'alcynyle de la chrysamine g destines au diagnostic avant la mort de la maladie d'alzheimer, a l'imagerie in vivo et a la prevention du depot de substance amyloide
L'invention concerne des composes se fixant a la substance amyloide et qui sont des derives non azo de la chrysamine G, des… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)